Myricx Bio

StartupBiotech & Life SciencesBritish

Biotech spinout from Imperial College London and the Francis Crick Institute developing a first-in-class class of antibody-drug conjugate payloads based on N-myristoyltransferase (NMT) inhibitors to treat cancer, with lead programmes targeting B7-H3 and HER2.

Locations

London, United Kingdom (Headquarters)

London Innovation Centre, 20 Water Street, Canary Wharf, London, Greater London, E14 5GX, United Kingdom

View on map